Collectively, IL-22 may promote tumor cell invasion and metastasis by activating the PI3K/AKT signaling pathway, and inhibition of the PI3K/AKT signaling pathway may reverse the effects of IL-22 (Fig. 5). This evidence concerns the gene AKT1 and neoplasm.